Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
ES ›
ESPEROFLU
Trademark search for:
ESPEROFLU
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-02-04 — Application filed
2020-02-07 — Application filed
2020-02-07 — Application filed
2020-04-21 — Assigned to examiner
2020-04-22 — Final disposition recorded
2020-04-22 — Final disposition recorded
2020-04-22 — Final disposition recorded
2020-10-21 — Office action issued
2020-10-21 — Correspondence received in law office
2020-10-22 — Teas/email correspondence entered
2020-10-23 — Approved for pub - principal register
2020-11-11 — Notification of notice of publication e-mailed
2020-12-01 — Published for opposition
2020-12-01 — Official gazette publication confirmation e-mailed
2021-01-26 — Noa e-mailed - sou required from applicant
2021-07-08 — Attorney/dom.rep.revoked and/or appointed
2021-07-08 — Teas change of correspondence received
2021-07-08 — Teas revoke/app/change addr of atty/dom rep received
2021-07-08 — Teas withdrawal of attorney received-firm retains
2021-07-13 — Sou teas extension received
2021-07-13 — Sou extension 1 filed
2021-07-13 — Sou extension 1 granted
2021-07-15 — Notice of approval of extension request e-mailed
2022-01-25 — Sou teas extension received
2022-01-25 — Sou extension 2 filed
2022-01-25 — Sou extension 2 granted
2022-01-27 — Notice of approval of extension request e-mailed
2022-03-07 — Assigned to examiner
2022-07-12 — Sou teas extension received
2022-07-12 — Sou extension 3 filed
2022-07-12 — Sou extension 3 granted
2022-07-14 — Notice of approval of extension request e-mailed
2023-01-19 — Sou teas extension received
2023-01-19 — Sou extension 4 granted
2023-01-19 — Sou extension 4 filed
2023-01-21 — Notice of approval of extension request e-mailed
2023-07-25 — Sou teas extension received
2023-07-25 — Sou extension 5 filed
2023-08-03 — Case assigned to intent to use paralegal
2023-08-03 — Sou extension 5 granted
2023-08-04 — Notice of approval of extension request e-mailed
2024-02-26 — Application abandoned
2024-02-26 — Application abandoned
2024-02-26 — Final status recorded
Owner Information
Esperovax, Inc.
Esperovax, Inc.
Correspondent
J. Matthew Buchanan MacMillan, Sobanski & Todd, LLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
